BioNTech SE BNTX has filed a patent infringement lawsuit against Moderna Inc. MRNA, alleging that Moderna's next-generation ...
The 2025-2026 COVID-19 vaccine formulation targets the SARS-CoV-2 sublineage LP.8.1, in line with FDA guidance to more closely match circulating strains1 Shipping of the LP.8.1-adapted vaccine will ...
Add Yahoo as a preferred source to see more of our stories on Google. A vial of the Pfizer/BioNTech Comirnaty vaccine against Covid-19 at a mass vaccination center on July 1, 2021 in Leipzig, Germany.
BioNTech has filed a lawsuit against Moderna in a Delaware federal court over allegations of patent infringement related to ...
Feb 19 (Reuters) - German biopharmaceutical company BioNTech sued Moderna in Delaware federal court on Thursday, alleging ...
Comirnaty (COVID-19 Vaccine, mRNA) mRNA COVID-19 vaccine (2025-2026 formulation targeting the LP.8.1 variant) For active immunization to prevent COVID-19 caused by SARS-CoV-2 in adults aged 65 years ...
Moderna (MRNA) faces a lawsuit in the U.S. for allegedly infringing patent rights related to the COVID-19 shot developed by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results